CapyFin

Calendar Reports

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

TransMedics - CapyFin

TransMedics

TMDX · NASDAQ🇺🇸

Earnings Dividends Seasonality Metrics

Reports earnings tomorrow

after market closes

Previous year: $109M

Previous year: $0.12

Previous year: 56%

R&D and Clinical Trials Expense

Previous year: $14.3M

Previous year: $42.7M

Previous year: $60.8M

Cash and Equivalents

Previous year: $330M

Previous year: $786M

Loading...

Key Statistics

Market Cap

$4.59B

P/E Ratio

54.25

Sector

N/A

Industry

N/A

52-Week High

$150

52-Week Low

$64.2

Gross Margin

59%

R&D and Clinical Trials Expense

$15.3M

SG&A Expense

$46M

Stock Compensation Expense

$8.7M

Total Operating Expenses

$61.3M

TransMedics

Unlock previous datapoints

TransMedics

Unlock previous datapoints

TransMedics Revenue by Segment

Revenue by Segment

Net Product Revenue

CapyFin.com

Service Revenue

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...